Atricure to participate in the canaccord genuity 44th annual global growth conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming canaccord genuity 44th annual global growth conference. atricure's management is scheduled to present on tuesday, august 13, 2024, at 10:30 am est. interested parties may access a live audio webcast of.
ATRC Ratings Summary
ATRC Quant Ranking